Jennifer L Shah, MD

Jennifer L. Shah
Clinical Associate Professor of Radiation Oncology and Program Director
Radiation Oncology
Medical School
Michigan Medicine
Radiation Oncology
1500 East Medical Center Drive
Ann Arbor, MI 48109
[email protected]
Available to mentor
Jennifer L Shah, MD
Jennifer L. Shah
Clinical Associate Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • Manage Your Profile

  • About

    I am a Clinical Associate Professor of Radiation Oncology at the University of Michigan. My clinical expertise is in the management of head and neck cancer including evaluating radiation treatment plans and prescribing radiation therapy for head and neck cancer patients. I have an active clinical practice. I am experienced in discussing clinical trials with patients and enrolling patients onto clinical trials. I am an active member of the multi-disciplinary head and neck cancer team at the University of Michigan. I participate in the multi-disciplinary tumor board meetings on a weekly basis. In addition, I am an active member of the head and neck cancer research team as indicated by my contributions to peer-reviewed publications.

    Administrative Assistant: Rebecca Roulo, [email protected]

    Qualifications

    • Health Equity Health Disparities Scholars Program
      Michigan Medicine, Office of Health, Equity, and Inclusion, Ann Arbor, United States
      2023 - 2024
      Residency
    • PGY II-V - Residency
      Stanford Medicine, Radiation Oncology, Stanford, United States
      2012 - 2016
      Residency
    • PGY I - Internship
      St Joseph Mercy Hospital, Ann Arbor, United States
      2011 - 2012
      Internship
    • MD, Doctor of Medicine
      University of Michigan Medical School, 1500 E Medical Center Dr, Ann Arbor, MI, 48109, United States
      2007 - 2011
    • BS, Nuclear Science & Engineering
      Massachusetts Institute of Technology, Cambridge, MA, United States
      2003 - 2007

    Center Memberships

    • Center Member
      Center for History, Humanities, Arts, Social Sciences and Ethics in Medicine
    • Center Member
      Institute for Healthcare Policy and Innovation

    Research Overview

    I am also academically focused on understanding barriers to clinical trial enrollment and developing tools to address these barriers. While some barriers result from patient attitudes and limitations, many barriers are system- or institution-based. By relying on patient education levels and patient resources, the clinical trial system perpetuates health care disparities. Our efforts to improve enrollment and reduce disparities should optimize the actionable elements of the clinical trial enrollment framework. At the University of Michigan, I am a faculty member of the Center for Bioethics and Social Sciences in Medicine as well as the Institute for Healthcare Policy and Innovation. This has allowed collaboration with other experts in these fields. I also was selected as a new member of the NRG Health Disparities Committee in 2020.

    Recent Publications

    See All Publications
    • Journal Article
      Association of routine electronic symptom monitoring with reduced opioid use in patients with head and neck cancers.
      Gharzai LA, Liu Y, Sun Z, Garcia M, Rothrock NE, Cella D, Suresh K, Stepan K, Shaunfield S, Forner D, Casper K, Shah JL, Mayo C, Tang X, Rosen B, Mierzwa ML. Journal of Clinical Oncology, 2026 May 29; 44 (16_suppl): 1579 - 1579. DOI:10.1200/jco.2026.44.16_suppl.1579
    • Journal Article
      Late Recurrences Beyond Five Years in Salivary Adenoid Cystic Carcinoma: Implications for Long-Term Surveillance
      Dalal PJ, Dermody SM, Ali H, Brummel C, Chad Brenner J, Buchakjian M, Casper KA, Chinn SB, Forner D, Hasan D, Malloy KM, McHugh J, Mierzwa M, Heft Neal ME, Prince ME, Shah J, Shuman AG, Stucken CL, Spector ME, Yalamanchi P, Worden FP, Swiecicki PL. Oto Open, 2026 Apr 1; 10 (2): DOI:10.1002/oto2.70259
    • Additional Scholarship
      Data from FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
      Mierzwa M, Rosen B, Suresh K, Dinesh A, Regan S, Brummel C, Wong K, Casper K, Prince M, Malloy K, Shuman A, Chinn S, Cao Y, Aryal M, Heft-Neal M, Stucken C, Buchakjian M, Forner D, Yalamanchi P, Swiecicki P, Lawrence TS, Akhdar R, Tewari M, Bhambhani C, Walline H, Brenner JC, Shah J, Worden F. 2026 Feb 17; DOI:10.1158/1078-0432.c.8313715
    • Journal Article
      FDG-PET-Based Selective Deescalation of Chemoradiation in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
      Mierzwa M, Rosen B, Suresh K, Dinesh A, Regan S, Brummel C, Wong K, Casper K, Prince M, Malloy K, Shuman A, Chinn S, Cao Y, Aryal M, Heft-Neal M, Stucken C, Buchakjian M, Forner D, Yalamanchi P, Swiecicki P, Lawrence TS, Akhdar R, Tewari M, Bhambhani C, Walline H, Brenner JC, Shah J, Worden F. Clinical Cancer Research an Official Journal of the American Association for Cancer Research, 2026 Feb 17; 32 (4): 684 - 693. DOI:10.1158/1078-0432.CCR-25-2820
      PMID: 41385605
    • Additional Scholarship
      Supplementary Data 1 from FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
      Mierzwa M, Rosen B, Suresh K, Dinesh A, Regan S, Brummel C, Wong K, Casper K, Prince M, Malloy K, Shuman A, Chinn S, Cao Y, Aryal M, Heft-Neal M, Stucken C, Buchakjian M, Forner D, Yalamanchi P, Swiecicki P, Lawrence TS, Akhdar R, Tewari M, Bhambhani C, Walline H, Brenner JC, Shah J, Worden F. 2026 Feb 17; DOI:10.1158/1078-0432.31353226
    • Additional Scholarship
      Supplementary Figure 1 from FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
      Mierzwa M, Rosen B, Suresh K, Dinesh A, Regan S, Brummel C, Wong K, Casper K, Prince M, Malloy K, Shuman A, Chinn S, Cao Y, Aryal M, Heft-Neal M, Stucken C, Buchakjian M, Forner D, Yalamanchi P, Swiecicki P, Lawrence TS, Akhdar R, Tewari M, Bhambhani C, Walline H, Brenner JC, Shah J, Worden F. 2026 Feb 17; DOI:10.1158/1078-0432.31353223
    • Additional Scholarship
      Supplementary Figure 2 from FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
      Mierzwa M, Rosen B, Suresh K, Dinesh A, Regan S, Brummel C, Wong K, Casper K, Prince M, Malloy K, Shuman A, Chinn S, Cao Y, Aryal M, Heft-Neal M, Stucken C, Buchakjian M, Forner D, Yalamanchi P, Swiecicki P, Lawrence TS, Akhdar R, Tewari M, Bhambhani C, Walline H, Brenner JC, Shah J, Worden F. 2026 Feb 17; DOI:10.1158/1078-0432.31353220
    • Additional Scholarship
      Supplementary Figure 3 from FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
      Mierzwa M, Rosen B, Suresh K, Dinesh A, Regan S, Brummel C, Wong K, Casper K, Prince M, Malloy K, Shuman A, Chinn S, Cao Y, Aryal M, Heft-Neal M, Stucken C, Buchakjian M, Forner D, Yalamanchi P, Swiecicki P, Lawrence TS, Akhdar R, Tewari M, Bhambhani C, Walline H, Brenner JC, Shah J, Worden F. 2026 Feb 17; DOI:10.1158/1078-0432.31353217